Management of keratoconus: an updated review

• Published in: Frontiers in medicine 2023-06, Vol.10, p.1212314-1212314
• Main Authors: Deshmukh, Rashmi, Ong, Zun Zheng, Rampat, Radhika, Alió Del Barrio, Jorge L, Barua, Ankur, Ang, Marcus, Mehta, Jodhbir S, Said, Dalia G, Dua, Harminder S, Ambrósio, Jr, Renato, Ting, Darren Shu Jeng
• Format: Article
• Language: English
• Subjects: artificial intelligence; contact lens; cornea; corneal cross-linking; corneal transplant; Medicine; refractive surgery
• ISSN: 2296-858X; 2296-858X
• DOI: 10.3389/fmed.2023.1212314

Keratoconus is the most common corneal ectatic disorder. It is characterized by progressive corneal thinning with resultant irregular astigmatism and myopia. Its prevalence has been estimated at 1:375 to 1:2,000 people globally, with a considerably higher rate in the younger populations. Over the past two decades, there was a paradigm shift in the management of keratoconus. The treatment has expanded significantly from conservative management (e.g., spectacles and contact lenses wear) and penetrating keratoplasty to many other therapeutic and refractive modalities, including corneal cross-linking (with various protocols/techniques), combined CXL-keratorefractive surgeries, intracorneal ring segments, anterior lamellar keratoplasty, and more recently, Bowman's layer transplantation, stromal keratophakia, and stromal regeneration. Several recent large genome-wide association studies (GWAS) have identified important genetic mutations relevant to keratoconus, facilitating the development of potential gene therapy targeting keratoconus and halting the disease progression. In addition, attempts have been made to leverage the power of artificial intelligence-assisted algorithms in enabling earlier detection and progression prediction in keratoconus. In this review, we provide a comprehensive overview of the current and emerging treatment of keratoconus and propose a treatment algorithm for systematically guiding the management of this common clinical entity.